TURNING POINT THERAPEUTICS I (TPTX)

US90041T1088 - Common Stock

76.01  +0.52 (+0.69%)

After market: 75.99 -0.02 (-0.03%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
1.01M30.83M25.00M0.000.00
Operating Expenses
345.60M268.83M186.84M77.72M25.64M
Research and Development
248.90M192.98M113.41M57.94M21.06M
Selling, General, and Administrative Expenses
96.70M75.85M73.43M19.78M4.58M
Operating Income
-344.59M-238.00M-161.84M-77.72M-25.64M
Interest Income/Expense
N/AN/A0.005.59M860.00K
Other Income/Expense
2.29M1.45M4.54MN/AN/A
Income Before Taxes
-342.31M-236.55M-157.29M-72.13M-24.78M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-342.31M-236.55M-157.29M-72.13M-24.79M
EBITDA
-343.10M-236.79M-160.96M-77.23M-25.50M
 
Per Share Data
EPS Diluted Total Ops
-6.90-4.80-3.85-2.99-0.84
Non GAAP EPS
N/A-4.79-3.07-5.88N/A
 
Statistics
Profit Margin
-33959.03%-767.30%-629.16%N/AN/A
Operating Profit Margin
-34185.81%-772.00%-647.36%N/AN/A

All data in USD

Charts